E Dannaoui
Overview
Explore the profile of E Dannaoui including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
2201
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Guitard J, Bellanger A, Dorin J, Cassaing S, Capitaine A, Gabriel F, et al.
J Mycol Med
. 2024 Jun;
34(3):101490.
PMID: 38852225
Due to large outbreaks observed worldwide, Candida auris has emerged as a major threat to healthcare facilities. To prevent these phenomena, a systematic screening should be performed in patients transferred...
2.
Espinel-Ingroff A, Sasso M, Turnidge J, Arendrup M, Botterel F, Bourgeois N, et al.
Antimicrob Agents Chemother
. 2021 Aug;
65(11):e0109321.
PMID: 34370582
Susceptibility testing is an important tool in the clinical setting; its utility is based on the availability of categorical endpoints, breakpoints (BPs), or epidemiological cutoff values (ECVs/ECOFFs). CLSI and EUCAST...
3.
Djenontin E, Lebeaux D, Acikgoz H, Rammaert B, Bougnoux M, Rouzaud C, et al.
J Mycol Med
. 2020 Apr;
30(2):100967.
PMID: 32321676
A 44-year-old woman, victim of a road accident in Mali was diagnosed with left knee arthritis. Joint effusion aspiration and subcutaneous surgical biopsies were positive for a melanized asexual ascomycete....
4.
Gangneux J, Bougnoux M, Dannaoui E, Cornet M, Zahar J
J Mycol Med
. 2020 Apr;
30(2):100971.
PMID: 32307254
No abstract available.
5.
Bidaud A, Djenontin E, Botterel F, Chowdhary A, Dannaoui E
Int J Antimicrob Agents
. 2020 Jan;
55(3):105901.
PMID: 31954831
Antifungal combination is an interesting approach for the treatment of several fungal infections but there is currently little evidence to support combined therapy in Candida auris infections. The antibacterial colistin...
6.
Delliere S, Verdurme L, Bigot J, Dannaoui E, Senghor Y, Botterel F, et al.
Antimicrob Agents Chemother
. 2019 Dec;
64(3).
PMID: 31844011
Reference methods used to assess the drug susceptibilities of isolates consisted of EUCAST and CLSI standardized broth microdilution techniques. Considering the increasing rate and the potential impact on the clinical...
7.
Bidaud A, Botterel F, Chowdhary A, Dannaoui E
Antimicrob Agents Chemother
. 2019 Oct;
63(12).
PMID: 31591129
is an emerging, multidrug resistant pathogen, responsible for invasive hospital-acquired infections. Flucytosine is an effective anti- drug, but which cannot be used as a monotherapy because of the risk of...
8.
Salse M, Gangneux J, Cassaing S, Delhaes L, Fekkar A, Dupont D, et al.
Clin Microbiol Infect
. 2019 May;
25(12):1546-1552.
PMID: 31082487
Objectives: To determine the Etest-based epidemiological cut-off values (ECVs) for antifungal agents against the most frequent yeast and Aspergillus fumigatus species isolated in 12 French hospitals. Methods: For each antifungal...
9.
Espinel-Ingroff A, Turnidge J, Alastruey-Izquierdo A, Botterel F, Canton E, Castro C, et al.
Antimicrob Agents Chemother
. 2018 Oct;
63(1).
PMID: 30323038
Although the Sensititre Yeast-One (SYO) and Etest methods are widely utilized, interpretive criteria are not available for triazole susceptibility testing of or species. We collected fluconazole, itraconazole, posaconazole, and voriconazole...
10.
Bidaud A, Chowdhary A, Dannaoui E
J Mycol Med
. 2018 Jul;
28(3):568-573.
PMID: 30030072
Candida auris is an emerging fungal pathogen responsible for nosocomial invasive infection outbreaks on five continents. Large healthcare-related outbreaks of C. auris infection and colonization have been reported from different...